Peroxisome proliferator nafenopin potentiated cytotoxicity and genotoxicity of cyclophosphamide in the liver and bone marrow cells

Chemico-Biological Interactions

Volumn 105, Issue 2, 1997, Pages 81-97

  Voskoboinik, I ^a   Drew, R ^b   Ahokas, J T ^a  

^a RMIT UNIVERSITY   (Australia)

^b ICI Australia   (Australia)

Author keywords

Cyclophosphamide; Genotoxicity; Metabolism; Peroxisome proliferator

Indexed keywords

7 ETHOXYCOUMARIN DEETHYLASE; ANTINEOPLASTIC AGENT; CARCINOGEN; COLCHICINE; CYCLOPHOSPHAMIDE; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; MIXED FUNCTION OXIDASE; NAFENOPIN; PEROXISOME PROLIFERATOR; XENOBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW CELL; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CYTOTOXICITY; DETOXIFICATION; DRUG METABOLISM; DRUG POTENTIATION; ENZYME ACTIVITY; GENOTOXICITY; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; LIVER CARCINOGENESIS; MALE; METABOLIC ACTIVATION; MITOSIS RATE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLEIOTROPY; RAT;

7-ALKOXYCOUMARIN O-DEALKYLASE; ANIMALS; ANTILIPEMIC AGENTS; BONE MARROW; CELL DIVISION; CHROMOSOMES; CYCLOPHOSPHAMIDE; DRUG SYNERGISM; GLUTATHIONE TRANSFERASE; LIVER; LIVER NEOPLASMS; MALE; MICROBODIES; MODELS, CHEMICAL; MUTAGENS; NAFENOPIN; OXIDOREDUCTASES; RATS; RATS, WISTAR;

ANIMALIA; RODENTIA;

EID: 0030806757     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(97)00039-2     Document Type: Article

References (44)

1. J.K. Reddy, D.L. Azarnoff, C.E. Hignite, Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens, Nature 283 (1980) 397-398.
2. W.T. Stott, Chemically induced proliferation of peroxisomes: implications for risk assessment. Regul. Toxicol. Pharmacol. 8 (1988) 125-159.
3. J. Ashby, A. Brady, C.R. Elcombe, B.M. Elliott, J. Ishmael, J. Odum, J.D. Tugwood, S. Kettle, I.F.H. Purchase, Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis, Hum. Experim. Toxicol. 13 (1994) S1-S117.
4. H. Reisenbichler, P.M. Eckl, Genotoxic effects of selected peroxisome proliferators, Mutat. Res. 286 (1993) 135-144.
5. J.-J. Hwang, M.T.S. Hsia, R.L. Jirtle, Induction of sister chromatide exchange and micronuclei in primary cultures of rat and human hepatocytes by the peroxisome proliferator, Wy-14643, Mutat. Res. 286 (1993) 123-133.
6. B.G. Lake, Mechanisms of hepatocarcinogenicity of peroxisome proliferating drugs and chemicals, Annu. Rev. Pharmacol. Toxicol. 35 (1995) 483-507.
7. J.K. Reddy, M.S. Rao, D.L. Azarnoff, S. Sell, Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator. [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver, Cancer Res. 39 (1979) 152-161.
8. S. Green, Nuclear receptors and chemical carcinogenesis, Trends Pharmacol. Sci. 13 (1992) 251-255.
9. B. Grasl-Kraupp, T. Waldhor, W. Huber, R. Schulte-Hermann, Glutathione S-transfcrase isoenzyme patterns in different subtypes of enzyme-altered rat liver oci treated with the peroxisome proliferator nafenopin or with phenobarbital, Carcinogenesis 14 (1993) 2407-2412.
10. H. Schramm, T. Friedberg, L.W. Robertson, F. Oesch, W. Kissel, Perfluorodecanoic acid decreases the enzyme activity and the amount of glutathione S-transferases proteins and mRNAs in vivo, Chem.-Biol. Interact. 70 (1989) 127-143.
11. A. Foliot, D. Touchard, L. Mallet, Inhibition of liver glutathione S-transferase activity in rats by hypolipidemic drugs related or unrelated to clofibrate, Biochem. Pharmacol. 35 (1986) 1685-1690.
12. B. Lundgren, J.W. De Pierre, Induction of xenobiotic-metabolizing enzymes and peroxisome proliferation in rat liver caused by dietary exposure to di(2-ethylhexyl)phosphate, Xenobiotica 17 (1987) 585-593.
13. A. Takagi, K. Sai, T. Umemura, R. Hasegawa, Y. Kurokawa, Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators: di(2-ethylhexyl) phthalate, aluminium clofibrate and simfibrate, Cancer Lett. 53 (1990) 33-38.
14. M.E. Hegi, D. Ulrich, P. Sagelsdorff, C. Richter, W.K. Lutz, No measurable increase in thymidine glycol or 8-hydroxydeoxyguanosine in liver DNA of rats treated with nafenopin or choline-devoid low methionine diet, Mutat. Res. 238 (1990) 325-329.
15. W.K. Kaufmann, J.M. Rice, M.L. Wenk, D. Devor, D.G. Kaufmann. Cell cycle-dependent initiation of hepatocarcinogenesis in rats by methyl(acetoxymethyl)nitrosamine, Cancer Res. 47 (1987) 1263-1266.
16. F. Hayashi, H. Tamura, T. Watanabe, T. Suga, Enhancement by peroxisome proliferators of the susceptibility to DNA damage in the liver of male F344 rats. Cancer Lett. 92 (1995) 87-90.
17. M.A. Bacher, G.G. Gibson, Chlorophenoxyacid herbicides induce microsomal cytochrome P-450IVA1 (P-452) in rat liver, Chem.-Biol. Interact. 65 (1988) 145-156.
18. H.M. Wortelboer, C.A. de Kruif, A.A.J. van Iersel, H.E. Falke, J. Noordhoek, B.J. Blaauboer, Comparison of Cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures. The effects of model inducers on apoproteins and biotransformation activities, Biochem. Pharmacol. 42 (1991) 381-390.
19. G.F. Weber, D.J. Waxman, Activation of the anti-cancer drug ifosphamide by rat liver microsomal P450 enzymes, Biochem. Pharmacol. 45 (1993) 1685-1694.
20. A.S. Muerhoff, K.J. Griffin, E.F. Johnson, The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P-450 fatty acid w-hydroxylase, by clofibric acid, J. Biol. Chem. 267 (1992) 19051-19053.
21. I. Voskoboinik, J.T. Ahokas, R. Drew, Differential effect of peroxisome proliferators on rat glutathione S-transferase isoenzymes, Tox. Lett. 87 (1996) 147-155.
22. A.M. Rossi, M. Romano, L. Zaccaro, R. Pulci, M. Salmona, DNA synthesis, mitotic index, drug-metabolising systems and cytogenetic analysis in regenerating rat liver, Mutat. Res. 182 (1987) 75-82.
23. H.L. Gurtoo, J.H. Hipkens, S.D. Sharma, Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide, Cancer Res. 411 (1981) 3584-3591.
24. H.G. Payne, L.W. Nelson, J.H. Weikel, Effects of cyclophosphamide on somatic cell chromosomes in rats, Tox. Appl. Pharm. 30 (1974) 360-368.
25. A.J. Marinello, S.K. Bansal, B. Paul, P.L. Koser, J. Love, R.F. Struck, H.L. Gurtoo, Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450, Cancer Res. 44 (1984) 4615-4621.
26. S. Ranganathan, P.J. Ciaccio, K.D. Tew, Principles of drug modulation applied to glutathione S-transferase, in: K.D. Tew, C.B. Pickett, T.J. Mantle, B. Mannervik, J.D. Hayes (Eds.), Structure and function of glutathione S-transferases, CRC Press, Boca Raton, 1993, pp. 249-256.
27. C. Bai, N. Stacey, Mechanism of trichloroethylene-induced elevation of individual serum bile acids, Tox. Appl. Pharm. 121 (1993) 296-302.
28. M. Berry, D. Friend, High yield preparation of of isolated rat liver parenchymal cells: A biochemical and structural studies, J. Cell Biol. 43 (1969) 506-520.
29. T. Alati, P. Eckl, R.L. Jirtle, An in vitro micronucleus assay for determining the radiosensitivity of hepatocytes, Radiat. Res. 119 (1989) 562-568.
30. A. Aitio, A simple and sensitive assay of 7-ethoxycoumarin deethylation, Analyt. Biochem. 85 (1978) 488-491.
31. W.H. Habig, MJ. Pabst, W.B. Jakoby, Glutathione S-transferase - the first enzymatic step in mercapturic acid formation, J. Biol. Chem. 249 (1974) 7130-7139.
32. P.B. Lazarow, Assay of peroxisomal betta-oxidation of fatty acids, Methods Enzym. 72 (1981) 315-317.
33. O.H. Lowry, N. Rosebrough, A. Farr, R. Randall, Protein measurement with the folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
34. P.J. van Bladeren, B. van Ommen, The inhibition of glutathione S-transferases: mechanisms, toxic consequences and therapeutic benefits, Pharmac. Ther. 51 (1991) 35-46.
35. C.H. Brown, P.P. Carbone, Effects of chemotherapeutic agents on normal mouse bone marrow growth in vitro, Cancer Res. 31 (1971) 185-190.
36. W. Werner, M. Haller, V. Hoepfner, J. Kuechler, J. Ziervogel, On haematotoxic effects due to cyclophosphamide dosage in rats, Exp Path. 5 (1971) 123-127.
37. D.L. Hill, A review of cyclophosphamide, Charles C. Thomas Publisher, Springfield, 1975, pp. 113-119.
38. F.D. Hayes, R.D. Short, J.E. Gibson, A correlation between cyclophosphamide induced leukopenia in mice and the presence of alkylating metabolites, Proc. Soc. Exp. Biol. Med. 139 (1972) 417-421.
39. T.R. Stott, R.E. Kirsch, Inhibition of rat liver glutathione S-transferase isoenzymes by acrolein, Biochem. Internat. 16 (1988) 439-442.
40. J. Ashby, P.A. Lefevre, Mitogenesis, micronuclei, and carcinogenesis in the rat liver: Some basic inconsistencies, Envir. Molec. Mutagen. 20 (1992) 29-38.
41. J.A. Styles, A. Bybee, N.R. Pritchard, M.D. Kelly, Studies on the hyperplastic responsiveness of binucleated rat hepatocytes, Carcinogenesis 11 (1990) 1149-1152.
42. K. Gorgas, S.K. Krisans, Zonal heterogeneity of peroxisome proliferation and morphology in rat liver after gemfibrozil treatment, J. Lipid Res. 30 (1989) 1859-1875.
43. W. Parzefall, E. Erber, R. Sedivy, R. Schulte-Hermann, Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters. Cancer Res. 51 (1991) 1143-1147.
44. J.A. Styles, M.D. Kelly, N.R. Pritchard, C.R. Elcombe, Acute hyperplasia and peroxisome proliferation induced by methylclofenapate: a species comparison and implications for liver carcinogenesis, Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons, 1990, pp. 385-393.